In an update shared today, uniQure announced alignment with the US drug regulator on key criteria for accelerated approval of ...

Vico Therapeutics have shared interim data about their drug, VO659, which targets the CAG expansion that causes several ...

A new Phase 1 clinical trial for the huntingtin-lowering drug ALN-HTT02 was initiated this week with the first dose given.

In plain language. Written by scientists. For the global HD community.

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...

Leora Fox trained as a Huntington's Disease scientist, and obtained her PhD in 2016 at Columbia University, where she studied HD mouse models and how brain cells dispose of huntingtin protein. After ...

You can also read About HDBuzz for information on HDBuzz or try your search on a search engine. Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be ...

Dr. Sarah Hernandez is the Director of Research Programs at the Hereditary Disease Foundation (HDF). She carried out her postdoctoral work with Dr. Leslie Thompson at the University of California, ...

Ed is a neurologist at the National Hospital for Neurology and Neurosurgery, London, UK, and a Professor of Neurology at University College London where he is Associate Director of the Huntington’s ...

Deepti is a board-certified genetic counsellor at the University of Alberta in Edmonton. She did her genetic counselling training in New York and has practiced for over a decade in both the U.S. and ...

Please consider making a donation if you value the services that HDBuzz provides. We want HDBuzz to be sustainable so that we can continue to report unbiased science to the HD community. With your ...